TACHYKININ RECEPTORS AND THE AIRWAYS

被引:74
作者
FROSSARD, N [1 ]
ADVENIER, C [1 ]
机构
[1] UNIV PARIS 05, PHARMACOL LAB, F-75006 PARIS, FRANCE
关键词
D O I
10.1016/0024-3205(91)90636-P
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The tachykinins, substance P, neurokinin A and neurokinin B, belong to a structural family of peptides. In mammalian airways, substance P and neurokinin A are colocalized to afferent C-fibres. Substance P-containing fibres are close to bronchial epithelium, smooth muscle, mucus glands and blood vessels. Sensory neuropeptides may be released locally, possibly as a result of a local reflex, and produce bronchial obstruction through activation of specific receptors on these various tissues. Three types of tachykinin receptors, namely NK-1, NK-2 and NK-3 receptors, have been characterized by preferential activation by substance P, neurokinin A and neurokinin B respectively. NK-1 and NK-2 receptors were recently cloned. The determination of receptor types involved in the effects of tachykinins in the airways has been done with synthetic agonists and antagonists binding specifically to NK-1, NK-2 and NK-3 receptors. Although the existence of species differences, the conclusion that bronchial smooth muscle contraction is mainly related to activation of NK-2 receptors on bronchial smooth muscle cell has been drawn. The hypothesis of a NK-2 receptor subclassification has been proposed with NK-2A receptor subtype in the guinea-pig airways. Other effects in the airways are related to stimulation of NK-1 receptors on mucus cells, vessels, epithelium and inflammatory cells. A non-receptor-mediated mechanism is also involved in the effect of substance P on inflammatory cells and mast cells.
引用
收藏
页码:1941 / 1953
页数:13
相关论文
共 114 条
[1]   RELATIVE POTENCIES OF NEUROKININS IN GUINEA-PIG TRACHEA AND HUMAN BRONCHUS [J].
ADVENIER, C ;
NALINE, E ;
DRAPEAU, G ;
REGOLI, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (02) :133-137
[2]  
ALBAZZAZ FJ, 1985, AM REV RESPIR DIS, V131, P86
[3]  
AURSUDKIJ B, 1988, J PHYSIOL-LONDON, V398, pP51
[4]  
BARANIUK J N, 1991, American Review of Respiratory Disease, V143, pA40
[5]   NEUROPEPTIDES IN HUMAN AIRWAYS - FUNCTION AND CLINICAL IMPLICATIONS [J].
BARNES, PJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (06) :S77-S83
[6]   HISTAMINE IS RELEASED FROM SKIN BY SUBSTANCE-P BUT DOES NOT ACT AS THE FINAL VASODILATOR IN THE AXON REFLEX [J].
BARNES, PJ ;
BROWN, MJ ;
DOLLERY, CT ;
FULLER, RW ;
HEAVEY, DJ ;
IND, PW .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (04) :741-745
[7]  
BARNES PJ, 1986, LANCET, V1, P242
[8]   ENHANCEMENT OF PHAGOCYTOSIS - A NEWLY FOUND ACTIVITY OF SUBSTANCE-P RESIDING IN ITS N-TERMINAL TETRAPEPTIDE SEQUENCE [J].
BARSHAVIT, Z ;
GOLDMAN, R ;
STABINSKY, Y ;
GOTTLIEB, P ;
FRIDKIN, M ;
TEICHBERG, VI ;
BLUMBERG, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 94 (04) :1445-1451
[9]   DIFFERENTIAL RELEASE OF HISTAMINE AND EICOSANOIDS FROM HUMAN-SKIN MAST-CELLS ACTIVATED BY IGE-DEPENDENT AND NON-IMMUNOLOGICAL STIMULI [J].
BENYON, RC ;
ROBINSON, C ;
CHURCH, MK .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (03) :898-904
[10]  
Black J L, 1988, Pulm Pharmacol, V1, P21, DOI 10.1016/0952-0600(88)90006-3